Same day dispatch Card & Apple Pay accepted

Semax research product — Tested Peptides
Out of Stock

$70

Independent Testing

Certificate library →

Ozcanium Analytics

Independent Australian laboratory. One report covers every vial size; each opens as issued. We run no analysis of our own.

Purity & identity

99.25%

Analysed
28 August 2026
Method
UPLC-MS/MS
Lot
25/08/2026
Net content
9.86 mg
Code
OZ-HPLCMS-TP09
Open purity reportPDF (opens in a new tab)

Bacterial endotoxin

< 15.0EU/vial

Below the reportable limit at the dilution tested

Analysed
28 August 2026
Method
kinetic chromogenic LAL
Code
OZ-ENDOTX-TPA4
Open endotoxin reportPDF (opens in a new tab)

Enter a code in the Ozcanium verification portal (opens in a new tab) to confirm either report against the lab's own records.

Full testing statement

Semax is independently tested by Ozcanium Analytics, an independent Australian laboratory, at 99.25% purity by UPLC-MS/MS, analysed 28 August 2026 on lot 25/08/2026, net content 9.86 mg, verification code OZ-HPLCMS-TP09; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 28 August 2026, verification code OZ-ENDOTX-TPA4.

Molecular Details

Sequence:Met-Glu-His-Phe-Pro-Gly-Pro
Molecular Formula:C37H51N9O10S
Molecular Weight:813.9 Da
Purity:99.25%(Ozcanium Analytics)
CAS Number:80714-61-0
Form:Lyophilised powder
Appearance:White/off-white lyophilised powder

Usage & Storage

Quantity:10mg / vial
Reconstitution:Reconstitute with 2mL bacteriostatic water. Swirl gently; do not shake. Allow to stand until fully dissolved.
Storage Temp:-20°C for long-term storage
Storage Conditions:Store lyophilised at -20°C, protected from light. After reconstitution, refrigerate at 2-8°C and use within 28 days.
Packaging:Sterile, tamper-evident research vial

Description

ACTH(4-7) analogue heptapeptide with Pro-Gly-Pro stabilisation. Studied in neuroprotection, BDNF expression, and cognition research models.

  • Synthetic heptapeptide ACTH(4-7) analogue
  • C-terminal Pro-Gly-Pro motif resists enzymatic degradation
  • Studied in BDNF and NGF expression research
  • Investigated in cerebral ischaemia and neuroprotection models
  • Research Grade purity >=98%

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), identified by CAS number 80714-61-0. It consists of the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro motif — a modification that markedly increases resistance to enzymatic degradation while removing the corticotropic activity of the parent hormone. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has been characterised extensively in preclinical neurological research. Studies have examined its influence on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, its modulation of dopaminergic and serotonergic signalling, and its activity in cerebral ischaemia and neuroprotection models. Further research has investigated its effects on inflammatory and immune signalling within neural tissue, and its behaviour in learning, memory and attention research models. Supplied as a lyophilised white powder with a molecular weight of 813.9 Da and molecular formula C37H51N9O10S. Supplied strictly for in-vitro laboratory research. Not for human or veterinary consumption.

Frequently Asked Questions

Is Semax legal to buy in Australia?

Semax is supplied strictly as a research chemical for in-vitro laboratory use. It is not approved for human therapeutic use in Australia and is not for human or animal consumption. Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols.

Is Semax third-party tested?

Yes. Semax is independently tested by Ozcanium Analytics, an independent Australian laboratory, at 99.25% purity by UPLC-MS/MS, analysed 28 August 2026 on lot 25/08/2026, net content 9.86 mg, verification code OZ-HPLCMS-TP09; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 28 August 2026, verification code OZ-ENDOTX-TPA4. The certificates are published in full on this page, and each verification code can be redeemed in the laboratory's own portal, so the document is confirmed against their records rather than ours.

What purity is Semax?

Semax is independently tested by Ozcanium Analytics at 99.25% purity by UPLC-MS/MS, analysed 28 August 2026. That is the laboratory's measurement of the lot it tested, not a figure of ours: Tested Peptides runs no analysis of its own.

Is there a Certificate of Analysis (COA) for Semax?

Yes. The Semax Certificate of Analysis is issued by Ozcanium Analytics, an independent Australian laboratory, and published in full at testedpeptides.com.au/certificates/semax. Testing is commissioned per compound and repeated periodically, and the current certificate replaces the last, so it is the most recent independent result for Semax rather than a test of every lot.

Where can I buy Semax in Australia?

Semax can be ordered here from Tested Peptides for in-vitro research use, dispatched same day from within Australia.

Do you provide dosing or administration guidance for Semax?

No. As these compounds are supplied for laboratory research only, we do not provide dosing or administration protocols. Our research library covers reconstitution and concentration calculations for in-vitro work.